Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

ASPAVELI 1080 mg solution for infusion {equilateral_black_triangle}

Active Ingredient:
pegcetacoplan
Company:  
Swedish Orphan Biovitrum Ltd See contact details
ATC code: 
L04AJ03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Aspaveli - Guide for Healthcare Professional

{healthcare_pro_orange} For Healthcare Professionals

Important Information to communicate to patients/caregivers prior to prescribing ASPAVELI (pegcetacoplan)

{pdf_link}

Aspaveli - Guide for Patient and Caregivers

This guide contains important information and safety considerations for pegcetacoplan, including the risk of serious infections (including meningitis) and guidance on self administration.

{pdf_link}

Aspaveli - Patient Card

Important information for patients taking Aspaveli (pegcetacoplan)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Swedish Orphan Biovitrum Ltd
Company image
Address
Suite 2, Riverside 3, Granta Park, Great Abington,, Cambridgeshire, CB21 6AD, UK
WWW
http://www.sobi.com
Telephone
+44 (0) 1223 891854
Medical Information Direct Line
+44 (0) 800 111 4754
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 800 111 4754